Maze Therapeutics Inc
(MAZE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 0 | 0 | 2,500 |
| Gross Profit | N/A | N/A | N/A | 0 | 2,500 |
| Operating Expenses | 32,965 | 36,474 | 35,401 | 29,726 | 26,729 |
| Operating Income | -32,965 | -36,474 | -35,401 | -29,726 | -24,229 |
| Other Income | 2,878 | 2,795 | 2,615 | -128 | -802 |
| Pre-tax Income | -30,087 | -33,679 | -32,786 | -29,854 | -25,031 |
| Income Tax | N/A | N/A | N/A | -275 | -279 |
| Net Income Continuous | -30,087 | -33,679 | -32,786 | -44,551 | -24,752 |
| Net Income | $-30,087 | $-33,679 | $-32,786 | $-44,551 | $-24,752 |
| EPS Basic Total Ops | -0.66 | -0.77 | -1.15 | -18.32 | -10.25 |
| EPS Basic Continuous Ops | -0.66 | -0.77 | -1.15 | -18.32 | -10.25 |
| EPS Diluted Total Ops | -0.66 | -0.77 | -1.15 | -18.32 | -10.25 |
| EPS Diluted Continuous Ops | -0.66 | -0.77 | -1.15 | -18.32 | -10.25 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -0.77 | -1.15 | -18.32 | N/A |
| EBITDA(a) | $-32,394 | $-35,825 | $-34,717 | $-29,021 | $-23,441 |